- Home
- LXP vs TMDX Comparison
LXP vs TMDX Comparison
Compare LXP & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXP
- TMDX
- Stock Information
- Founded
- LXP 1993
- TMDX 1998
- Country
- LXP United States
- TMDX United States
- Employees
- LXP N/A
- TMDX N/A
- Industry
- LXP Real Estate Investment Trusts
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LXP Real Estate
- TMDX Health Care
- Exchange
- LXP Nasdaq
- TMDX Nasdaq
- Market Cap
- LXP 2.6B
- TMDX 2.3B
- IPO Year
- LXP 1993
- TMDX 2019
- Fundamental
- Price
- LXP $8.74
- TMDX $123.56
- Analyst Decision
- LXP Hold
- TMDX Buy
- Analyst Count
- LXP 3
- TMDX 10
- Target Price
- LXP $10.50
- TMDX $127.33
- AVG Volume (30 Days)
- LXP 2.9M
- TMDX 830.9K
- Earning Date
- LXP 07-30-2025
- TMDX 07-30-2025
- Dividend Yield
- LXP 6.17%
- TMDX N/A
- EPS Growth
- LXP 402.06
- TMDX N/A
- EPS
- LXP 0.20
- TMDX 1.41
- Revenue
- LXP $361,070,000.00
- TMDX $488,227,000.00
- Revenue This Year
- LXP N/A
- TMDX $34.07
- Revenue Next Year
- LXP $7.28
- TMDX $20.76
- P/E Ratio
- LXP $44.66
- TMDX $87.63
- Revenue Growth
- LXP 5.67
- TMDX 64.43
- 52 Week Low
- LXP $6.85
- TMDX $55.00
- 52 Week High
- LXP $10.57
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- LXP 63.15
- TMDX 45.61
- Support Level
- LXP $8.46
- TMDX $139.31
- Resistance Level
- LXP $8.71
- TMDX $145.50
- Average True Range (ATR)
- LXP 0.15
- TMDX 5.88
- MACD
- LXP -0.01
- TMDX -2.71
- Stochastic Oscillator
- LXP 77.78
- TMDX 12.94
About LXP LXP Industrial Trust (Maryland REIT)
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.